Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers
2021 · Journal of Affective Disorders Reports · 68 citations
https://doi.org/10.1016/j.jadr.2021.100098
L
Lachlan Cribb
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
970
Citations
17
h-index
23
i10-index
Lachlan Cribb is an academic researcher from Australian Regenerative Medicine Institute. The author has contributed to research in topics: Sleep and related disorders & Dementia and Cognitive Impairment Research & Circadian rhythm and melatonin. The author has an h-index of 17, co-authored 56 publications.
ORCID: 0000-0001-5276-5249Papers by this author
worksNutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial
2018 · Journal of Affective Disorders · 59 citations
https://doi.org/10.1016/j.jad.2018.11.092
Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,
2018 · European Neuropsychopharmacology · 36 citations
https://doi.org/10.1016/j.euroneuro.2018.07.098
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
2019 · Psychopharmacology · 34 citations
https://doi.org/10.1007/s00213-019-05358-1
EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
2019 · European Journal of Nutrition · 29 citations
https://doi.org/10.1007/s00394-019-02090-6
Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review
2019 · Nutritional Neuroscience · 27 citations
https://doi.org/10.1080/1028415x.2019.1625222
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat